Comprehensive prognostic and immune analysis of sterol O-acyltransferase 1 in patients with hepatocellular carcinoma

Figure 7 Effects of sterol O-acyltransferase 1 and hub genes on liver hepatocellular carcinoma. A: Lasso regression of survival time and sterol O-acyltransferase 1 (SOAT1) and hub gene expression levels in liver hepatocellular carcinoma (LIHC); B: Risk score analysis of survival time and SOAT1 and hub gene expression levels in LIHC. 1, survival; 0, dead; C: Overall survival (OS) of LIHC patients between high and low CYP19A1 expression groups; D: Disease-specific survival (DSS) of LIHC patients between high and low CYP19A1 expression groups; E: Progression free interval of LIHC patients between high and low CYP19A1 expression groups; F: OS of LIHC patients between high and low UGT1A10 expression groups; G: DSS of LIHC patients between high and low UGT1A10 expression groups: H: Progression free interval of LIHC patients between high and low UGT1A10 expression groups. OS: Overall survival; DSS: Disease specific survival; PFI: Progression free interval.